We studied 60 consecutive autologous PBSCTs of 54 pre-treated patients with haematological malignancies at the Medical University Graz, Austria from August 2002 to June 2004. During this period, ...
Abstract PURPOSE: This multicenter, randomized, double-blind, active-control study was designed to determine whether a single subcutaneous injection of pegfilgrastim (SD/01, sustained-duration ...
The US Food and Drug Administration (FDA) has expanded the indication for tbo-filgrastim (Granix, Teva), now allowing it to be self-administered by patients and their caregivers. Tbo-filgrastim, a ...